Rathbones Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.93M | Sell |
|
|||||
|
2025
Q2 | $5.88M | Sell |
|
|||||
|
2025
Q1 | $5.46M | Sell |
|
|||||
|
2024
Q4 | $4.95M | Sell |
|
|||||
|
2024
Q3 | $6.46M | Sell |
|
|||||
|
2024
Q2 | $6.18M | Sell |
|
|||||
|
2024
Q1 | $5.77M | Sell |
|
|||||
|
2023
Q4 | $6.23M | Sell |
|
|||||
|
2023
Q3 | $6.6M | Buy |
|
|||||
|
2023
Q2 | $6.12M | Sell |
|
|||||
|
2023
Q1 | $5.68M | Sell |
|
|||||
|
2022
Q4 | $6.02M | Sell |
|
|||||
|
2022
Q3 | $6.21M | Sell |
|
|||||
|
2022
Q2 | $7.09M | Sell |
|
|||||
|
2022
Q1 | $7.91M | Sell |
|
|||||
|
2021
Q4 | $8.14M | Sell |
|
|||||
|
2021
Q3 | $7.73M | Sell |
|
|||||
|
2021
Q2 | $8.64M | Sell |
|
|||||
|
2021
Q1 | $8.24M | Sell |
|
|||||
|
2020
Q4 | $9.21M | Sell |
|
|||||
|
2020
Q3 | $8.63M | Sell |
|
|||||
|
2020
Q2 | $8.71M | Sell |
|
|||||
|
2020
Q1 | $8.24M | Sell |
|
|||||
|
2019
Q4 | $9.47M | Buy |
|
|||||
|
2019
Q3 | $8.59M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $250K | Hold |
|
|||||
|
2016
Q4 | $245K | Hold |
|
|||||
|
2016
Q3 | $265K | Hold |
|
|||||
|
2016
Q2 | $277K | Buy |
|
|||||
|
2016
Q1 | $240K | Hold |
|
|||||
|
2015
Q4 | $274K | Hold |
|
|||||
|
2015
Q3 | $304K | Hold |
|
|||||
|
2015
Q2 | $326K | Hold |
|
|||||
|
2015
Q1 | $326K | Sell |
|
|||||
|
2014
Q4 | $335K | Sell |
|
|||||
|
2014
Q3 | $483K | Hold |
|
|||||
|
2014
Q2 | $465K | Hold |
|
|||||
|
2014
Q1 | $437K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $508K | Hold |
|
|||||
|
2013
Q2 | $468K | Buy |
|